HighTower Advisors LLC lifted its holdings in AMETEK, Inc. (NYSE:AME - Free Report) by 4.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,822 shares of the technology company's stock after purchasing an additional 2,410 shares during the period. HighTower Advisors LLC's holdings in AMETEK were worth $9,093,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Olde Wealth Management LLC acquired a new position in shares of AMETEK in the 1st quarter worth $29,000. Annis Gardner Whiting Capital Advisors LLC boosted its position in shares of AMETEK by 57.7% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after purchasing an additional 71 shares during the period. Banque Transatlantique SA purchased a new position in AMETEK in the 4th quarter worth about $37,000. Zions Bancorporation National Association UT purchased a new stake in AMETEK during the first quarter valued at about $42,000. Finally, Minot DeBlois Advisors LLC acquired a new position in shares of AMETEK in the fourth quarter worth about $43,000. 87.43% of the stock is owned by institutional investors and hedge funds.
AMETEK Stock Up 0.2%
AME traded up $0.35 during trading on Thursday, reaching $183.69. 616,020 shares of the stock traded hands, compared to its average volume of 1,373,175. The stock's 50-day simple moving average is $180.81 and its two-hundred day simple moving average is $176.97. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04. AMETEK, Inc. has a fifty-two week low of $145.02 and a fifty-two week high of $198.33. The stock has a market cap of $42.42 billion, a price-to-earnings ratio of 29.59, a price-to-earnings-growth ratio of 2.67 and a beta of 1.10.
AMETEK (NYSE:AME - Get Free Report) last issued its earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.09. The company had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.74 billion. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The business's revenue was up 2.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.66 EPS. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. As a group, equities research analysts expect that AMETEK, Inc. will post 7.15 EPS for the current year.
AMETEK Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Monday, September 15th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, September 15th. AMETEK's payout ratio is presently 19.97%.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on the stock. Melius lowered shares of AMETEK from a "buy" rating to a "hold" rating and set a $192.00 price target on the stock. in a report on Monday, July 14th. Royal Bank Of Canada boosted their target price on shares of AMETEK from $209.00 to $212.00 and gave the company an "outperform" rating in a research note on Friday, August 1st. Mizuho raised their target price on AMETEK from $212.00 to $225.00 and gave the stock an "outperform" rating in a research report on Friday, August 1st. Truist Financial lifted their price target on AMETEK from $196.00 to $200.00 and gave the company a "buy" rating in a report on Monday, May 5th. Finally, DA Davidson upped their price target on AMETEK from $210.00 to $215.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Seven analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, AMETEK presently has an average rating of "Hold" and a consensus target price of $208.00.
Read Our Latest Stock Report on AMETEK
About AMETEK
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Further Reading

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.